- Home
- AGO vs ACLX Comparison
AGO vs ACLX Comparison
Compare AGO & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGO
- ACLX
- Stock Information
- Founded
- AGO 2003
- ACLX 2015
- Country
- AGO Bermuda
- ACLX United States
- Employees
- AGO N/A
- ACLX N/A
- Industry
- AGO Property-Casualty Insurers
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- AGO Finance
- ACLX Health Care
- Exchange
- AGO Nasdaq
- ACLX Nasdaq
- Market Cap
- AGO 3.9B
- ACLX 4.4B
- IPO Year
- AGO 2004
- ACLX 2022
- Fundamental
- Price
- AGO $81.55
- ACLX $88.61
- Analyst Decision
- AGO Buy
- ACLX Strong Buy
- Analyst Count
- AGO 2
- ACLX 13
- Target Price
- AGO $98.50
- ACLX $114.38
- AVG Volume (30 Days)
- AGO 268.2K
- ACLX 453.0K
- Earning Date
- AGO 11-06-2025
- ACLX 11-05-2025
- Dividend Yield
- AGO 1.67%
- ACLX N/A
- EPS Growth
- AGO N/A
- ACLX N/A
- EPS
- AGO 9.06
- ACLX N/A
- Revenue
- AGO $891,000,000.00
- ACLX $35,898,000.00
- Revenue This Year
- AGO N/A
- ACLX N/A
- Revenue Next Year
- AGO N/A
- ACLX $220.95
- P/E Ratio
- AGO $9.00
- ACLX N/A
- Revenue Growth
- AGO 3.01
- ACLX N/A
- 52 Week Low
- AGO $74.09
- ACLX $47.86
- 52 Week High
- AGO $96.50
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- AGO 47.73
- ACLX 57.31
- Support Level
- AGO $79.32
- ACLX $84.00
- Resistance Level
- AGO $83.05
- ACLX $92.34
- Average True Range (ATR)
- AGO 1.47
- ACLX 3.61
- MACD
- AGO 0.05
- ACLX -0.22
- Stochastic Oscillator
- AGO 52.46
- ACLX 61.55
About AGO Assured Guaranty Ltd.
Assured Guaranty Ltd. provides credit protection products to the United States and international public finance and structured finance markets and manages assets across collateralized loan obligations as well as opportunity funds and liquid funds that build on its corporate credit, asset-based finance, municipal, and healthcare experience. The company operates in two segments: the Insurance segment and the Asset Management segment. The majority of the revenue earned by the company is from the Insurance segment.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.